What it is
ClinicalTrials.gov is a public registry of clinical studies, run by the U.S. National Institutes of Health. Researchers and sponsors list studies there, so anyone can search by condition, treatment or location. A stem cell search can return studies of many different kinds, from early safety studies to large comparisons.
A listing is not an endorsement. Being registered does not mean a treatment works, is safe, or is approved by the FDA. A listing describes what a study intends to do, who may join, and where it takes place. Some entries are not legitimate research, so each one is worth reading carefully.
Regulatory status matters. Blood-forming stem cell transplants from cord blood or bone marrow, used for certain cancers and blood disorders, are the clearly FDA-approved use. Stem cell, MSC, bone marrow aspirate, adipose-derived, umbilical cord or Wharton's jelly, and exosome products marketed for joints, back pain, sports injuries, skin, anti-aging or hair loss are generally not FDA-approved for those uses, and the FDA has warned the public about unapproved stem cell clinics and products. A genuine study of such a product is research, not an established treatment.
How it’s traditionally been approached
Clinical trials have traditionally been how new medical products are studied before they can be considered for approval. Studies are usually reviewed by an ethics board, follow a written plan, and are meant to track participants' safety closely. Participants are generally asked to complete an informed consent process first.
In the stem cell field, established care and research have often sat side by side. Blood-forming stem cell transplants are an approved, long-standing part of care for certain cancers and blood disorders. Many other uses are still under investigation, and researchers study them in registered trials.
Some people turn to unregulated clinics that charge for unapproved products, sometimes calling them trials. Real research typically does not ask participants to pay for an unproven product in the way a clinic would, though some studies do involve costs, so this should always be asked about directly. Names, locations and plain descriptions of oversight are things a legitimate study can usually explain.
How the right provider may help
A licensed clinician, such as your own doctor or a specialist in your condition, may help you make sense of a listing. They can look at your health history and say whether a study seems relevant, whether its eligibility criteria might fit, and what alternatives exist. Only a licensed clinician can decide what is appropriate for you after an evaluation.
A visit to talk about a trial is generally a conversation. You might bring the study's registry number and printouts of the listing. Useful questions include: What exactly is being given, and what is its FDA status? Who oversees the study? What are the specific risks? What is the realistic chance of benefit? What are the alternatives, including doing nothing? What will I be responsible for in total costs? Can I leave at any time?
A provider may also help you compare the study with a second opinion, coordinate with the study team, and keep your regular care on track. Providers.plus lists licensed providers, and a vetted domestic provider is often a safer first step than treatment abroad. Nothing here promises any outcome.
The whole-person view
Body, mind and stress affect one another. Living with a serious or long-lasting condition can bring worry, hope and pressure to act fast, and those feelings can shape how persuasive a promising-sounding study feels. Taking time, sleeping, eating and staying connected to people you trust can support clearer decisions.
Body-based support such as that offered through Somatic Experiences may help some people notice and settle stress while they weigh options. Talk therapy through Therapists.plus may offer a space to work through uncertainty, fear or decision fatigue. These are possible supports alongside medical care, not replacements for it.
Somatic Experiences: nervous system regulation →Somatic Experiences: embodiment and movement →Therapists.plus: mind body connection →
Keep in mind
- Licensed professionals should guide care for serious conditions. A registry listing is not medical advice and does not replace an evaluation.
- Real risks of unapproved stem cell products include infection, immune reaction, tumor formation at the injection site, and permanent injury when products are injected into the eye or spine. The FDA has issued public warnings about unapproved products.
- Red flags: guarantees of results, words like "cure" or "regrow", refusal to name the product or its FDA status, pressure to decide quickly, and discouraging a second opinion. Treatment abroad is materially higher risk because safety, sourcing and regulatory standards differ and complications are harder to address from a distance.
- To report a suspected problem, you can use the FDA's MedWatch safety reporting program and your state medical board. For emergencies call 911; in a crisis call or text 988.
Not sure where to start? Answer a few gentle questions and choose who you’d like to hear from.
Frequently asked questions
What is ClinicalTrials.gov and how does it relate to stem cell research?
ClinicalTrials.gov is a public registry of clinical studies, run by the U.S. National Institutes of Health. You can search it for stem cell studies by condition, location or study status. A listing only describes a study, so it does not mean the treatment is safe, effective or FDA-approved.
Is a stem cell treatment listed on ClinicalTrials.gov FDA-approved?
Not necessarily. Being listed means a study is registered, not that its product is approved. Blood-forming stem cell transplants for certain cancers and blood disorders are the clearly FDA-approved use, while stem cell, exosome and similar products marketed for joints, back pain, skin, anti-aging or hair loss are generally not approved for those uses.
How can I tell if a stem cell clinical trial is legitimate?
Check that the study names its product, its sponsor and the oversight it has, and that it can explain its FDA status. Red flags include guaranteed results, "cure" or "regrow" language, pressure to decide fast, and discouraging a second opinion. Ask your own licensed clinician to review it with you.
Should I pay to join a stem cell clinical trial?
Ask for a full written disclosure of all costs before agreeing to anything. Some legitimate studies have costs, but a clinic charging for an unproven product and calling it a trial deserves extra caution. A legitimate study should answer cost questions plainly.
What should informed consent for a stem cell study include?
It should cover the exact product and its FDA status, specific risks, a realistic chance of benefit, alternatives including doing nothing, total cost disclosure, and your right to walk away. This is a checklist of things to look for, not a legal template, and this page is not a consent form.
Is a trial abroad safer than a clinic at home?
Not necessarily. Treatment abroad is materially higher risk because safety, sourcing and regulatory standards differ and complications are harder to manage from a distance. A vetted domestic provider or a registered trial near you is often a safer first step. To report a problem, use the FDA's MedWatch program and your state medical board.
Educational resource. Safe Stem Cells shares general information and connects people with independent providers. It is not medical advice, diagnosis or treatment. Talk with a licensed professional about your health.